Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Pfizer Inc
Pfizer Inc And Renovis Inc
Pfizer Inc Products Inc
Pfizer Inc Pfizer Products Inc
  

Pfizer Inc patents (2009 archive)

Recent patent applications related to Pfizer Inc. Pfizer Inc is listed as an Agent/Assignee. Note: Pfizer Inc may have other listings under different names/spellings. We're not affiliated with Pfizer Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "P" | Pfizer Inc-related inventors




Date Pfizer Inc patents (2009 archive) (updated weekly) - BOOKMARK this page
12/31/09Novel adjuvant compositions
12/24/09Method and apparatus for monitoring the performance of automated egg removal
12/24/09Benzoxazinone and benzoxazepinone oxazolidinones as antibacterial agents
12/24/09Carbonylamino pyrrolopyrazoles, potent kinase inhibitors
12/24/09Morpholine dopamine agonists for the treatment of pain
12/24/09Antibody ultrahumanization by predicted mature cdr blasting and cohort library generation and screening
12/24/09Substituted pyridylmethyl bicycliccarboxyamide compounds
12/17/09Cd40 antibody formulation and methods
12/17/09Combination therapy of (2r,z)-2-amino-2-cyclohexyl-n-(5-(1-methyl-1h-pyrazol-4-yl)-1-oxo-2,6-dihydro-1h-[1,2]diazepino[4,5,6-cd]indol-8-yl)acetamide
12/10/09Substituted pyrimidinones
12/10/09Process for the production of benzopyran-2-ol derivatives
12/10/09Method for substituted ih-imidazo[4,5-c] pyridines
12/03/09Benzimidazolone derivatives
12/03/09Hydroxy and alkoxy substituted ih-imidazonaphthyridines and methods
12/03/09Preparation of gamma-amino acids having affinity for the alpha-2-delta protein
11/26/09Immunogenic lhrh compositions and methods relating thereto
11/26/09Pharmaceutical salts of reboxetine
11/19/09Metabolites of 1-[6-(1-ethyl-1-hydroxy-propyl)-pyridin-3-yl]-3-[2-(4-methyl-piperazin-1-yl)-benzyl]-pyrrolidin-2-one as seratonin receptor antagonists
11/19/09Isocystene derivatives for the treatment of pain
11/12/09Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
11/05/09Antibacterial agents
11/05/09Imidazopyridine and imidazopyrimidine derivatives as antibacterial agents
11/05/09Anchored transferrin fusion protein libraries
10/29/09Morpholine dopamine agonists
10/29/09Pyridinone pyrazole urea and pyrimidinone pyrazole urea derivatives
10/22/09Compositions and methods for treating female sexual dysfunction
10/15/09Solid and semi-solid polymeric ionic conjugates
10/15/09Rna bioassay
10/08/09Substituted triazole derivatives as oxytocin antagonists
10/08/09Amine derivatives
10/08/09Substituted n-bicyclicalkyl bicycliccarboxyamide compounds
10/08/09Methods for treating bone cancer pain by administering a nerve growth factor antagonist antibody
10/01/09Method of treating attention deficit disorder
10/01/09Novel pharmaceuticals
10/01/09Pharmaceuticals
10/01/09Preparation of beta-amino acids having affinity for the alpha-2-delta protein
09/24/09Exendin fusion proteins
09/24/09Treatment of pulmonary hypertension
09/24/09Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors
09/17/09Methods for cultivating lawsonia intracellularis
09/10/09N protein mutants of porcine reproductive and respiratory syndrome virus
09/10/09Pharmaceutical compositions of atorvastatin
09/10/09Immunogenic lhrh compositions and methods relating thereto
09/10/09Combination of a selective noradrenaline reuptake unhibitor and a pdev inhibitor
09/10/09Pyrazole derivatives as 5-lo-inhibitors
09/10/09Cycloalkylamino acid derivatives
09/10/09Amino acid derivatives
09/03/09Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
09/03/09Process for annealing amorphous atorvastatin
09/03/09Substituted fused[1,2] imidazo[4,5c] ring compounds and methods
09/03/09Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods
09/03/09Pyrazole compounds
09/03/09Preparation of an atorvastatin intermediate
09/03/09Preparation of an atorvastatin intermediate
08/27/09Phosphospecific pak antibodies and diagnostic kits
08/27/09Pyrazole derivatives
08/27/09Novel triazolopyridine compounds for the treatment of inflammation
08/27/09Novel madcam antibodies
08/27/09Amide resorcinol compounds
08/27/09S-[2-[(1-lminoethy)amino]ethyl]-2-methyl-l-cysteine maleate hydrochloride crystalline salt
08/20/09Formulation for stimulating hair growth
08/20/09Chemical compounds
08/20/09Novel triazolopyridine compounds
08/13/09Chemically modified human growth hormone receptor antagonist conjugates
08/13/09Alpha 2 delta ligands for fibromyalgia and other disorders
08/06/09Pharmaceutical compositions of atorvastatin
08/06/09Method for the preparation of aryl ethers
08/06/09Chemokine antagonists as treatment for obesity-related and metabolic syndrome-related conditions
08/06/09Pyridinyl amides for the treatment of cns and metabolic disorders
07/30/09Androgen modulators
07/30/09Metabolic phenotyping
07/09/09Bicyclic heteroaryl compounds as pde10 inhibitors
07/09/09Treatment of male sexual dysfunction
07/02/09Controlled release polymeric compositions of bone growth promoting compounds
07/02/09Inhibitors of the hiv integrase enzyme
07/02/09Androgen modulators
07/02/09Antibodies to cd40
07/02/09Pyy agonists and uses thereof
07/02/09Novel pyrazole-based hmg coa reductase inhibitors
07/02/09Pyy agonists and uses thereof
07/02/09Solid adsorbates of hydrophobic drugs
07/02/09Method of treating neuropathic pain
06/25/09Phosphodiesterase 10 inhibition as treatment for obesity-related and metabolic syndrome-related conditions
06/25/09Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins
06/18/091-(1- (2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino) - 1h-pyrazolo [4,3-d] pyrimidin-5-yl) piperidine-4-carboxylic acid and salts thereof
06/18/09Gabapentin-containing solid compositions and process for preparing the same
06/18/09(r)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity
06/11/09Oxazolidinones containing oxindoles as antibacterial agents
06/04/09Pharmaceutical dosage forms comprising a low-solubility drug and a polymer
06/04/09Sustained-release tablet composition
06/04/09Method of stimulating hair growth
05/28/09Substituted bicyclolactam compounds
05/28/09Thiazepine oxazolidinones as antibacterial agents
05/28/09Heterocyclic compounds
05/28/09Tetrazolyl-methylene amino acid derivatives
05/21/09Antibodies to cd40
05/21/09Estrogen modulators
05/21/09Histamine-3 receptor antagonists
05/14/09Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in alzheimer's disease
05/14/09Chemical compounds
05/14/09Chemical compounds
05/14/09C1-symmetric bisphospine ligands and their use in the asymmetric synthesis of pregabalin
05/07/09Statin-carboxyalkylether combinations
04/30/09Bicyclic heteroaromatic derivatives useful as anticancer agents
04/30/09Anti-m-csf antibody compositions
04/16/09Compounds useful in therapy
04/16/09Process for preparation of 1-(2s,3s)-2-benzhydryl-n-(5- tert-butyl-2-methoxybenzyl)quinuclidin-3-amine
04/09/091, 2, 3, 3a, 8, 8a-hexahydro-2, 7a-diada-cyclopenta[a]inden-7-one derivatives which bind to neuronal nicotinic acetylcholine specific receptor sites and are useful in modulating cholinergic function and in the treatment of addictive disorders
04/09/09Pyrrole, thiophene, furan, imidazole, oxazole, and thiazole derivatives
04/02/09Combination motif immune stimulatory oligonucleotides with improved activity
03/26/09Combinations and methods of using an immunomodulatory oligodeoxynucleotide
03/12/09Substituted azacycloalkanes useful for treating cns conditions
03/12/09Alpha-2-delta ligands for non-restorative sleep
02/26/09Sulfonyl amide derivatives for the treatment of abnormal cell growth
02/19/09Salt forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid
02/19/09Salts and polymorphs of a vegf-r inhibitor
02/19/09Pyridine derivatives
02/05/09Substituted bicyclolactam compounds
02/05/09Melanocortin type 4 receptor agonist piperidinoylpyrrolidines
02/05/09Compounds
02/05/09Combinations
02/05/09Combinations comprising alpha-2-delta ligands and ep4 receptor antagonists
03/19/09Worker safety management system
03/19/09Anti-ctla4 antibody and indolinone combination therapy for treatment of cancer







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Pfizer Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Pfizer Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';